Investor profile
Harbright Ventures
Cary early-stage investment group backing medical technology, industrial technology, clean or green technology, and B2B SaaS companies. Harbright Ventures led SonoVascular's $6M Series A first close in 2026.
Directory portfolio
Companies connected here
1
Latest company funding first, including rounds involving other investors. Unknown dates last.
Portfolio coverage reflects public company-investor links tracked in this directory and may not represent the investor's full portfolio.